Cited by 734SARS-CoV-2 and COVID-19 ResearchT-cell and B-cell ImmunologyCOVID-19 Clinical Research Studies

The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.

Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19

Open access

Kaneko, Naoki, Kuo, Hsiao-Hsuan, Boucau, Julie, Farmer, Jocelyn R., Allard-Chamard, Hugues, Mahajan, Vinay S., Piechocka-Trocha, Alicja, Lefteri, Kristina, Osborn, Matthew, Bals, Julia, Bartsch, Yannic C., Bonheur, Nathalie, Caradonna, Timothy M., Chevalier, Josh, Chowdhury, Fatema, Diefenbach, Thomas J., Einkauf, Kevin, Fallon, Jon, Feldman, Jared, Finn, Kelsey K., Garcia-Broncano, Pilar, Hartana, Ciputra Adijaya, Hauser, Blake M., Jiang, Chenyang, Kaplonek, Paulina, Karpell, Marshall, Koscher, Eric C., Lian, Xiaodong, Liu, Hang, Liu, Jinqing, Ly, Ngoc L., Michell, Ashlin R., Rassadkina, Yelizaveta, Seiger, Kyra, Sessa, Libera, Shin, Sally, Singh, Nishant, Sun, Weiwei, Sun, Xiaoming, Ticheli, Hannah J., Waring, Michael T., Zhu, Alex L., Alter, Galit, Li, Jonathan Z., Lingwood, Daniel, Schmidt, Aaron G., Lichterfeld, Mathias, Walker, Bruce D., Yu, Xu G., Padera, Robert F., Pillai, Shiv·2020·Cell

DOI 10.1016/j.cell.2020.08.025PMC PMC7437499

Open this paper in CoChat — free account Open PDF

Abstract

Humoral responses in coronavirus disease 2019 (COVID-19) are often of limited durability, as seen with other human coronavirus epidemics. To address the underlying etiology, we examined post mortem thoracic lymph nodes and spleens in acute SARS-CoV-2 infection and observed the absence of germinal centers and a striking reduction in Bcl-6+ germinal center B cells but preservation of AID+ B cells. Absence of germinal centers correlated with an early specific block in Bcl-6+ T FH cell differentiation together with an increase in T-bet+ T H1 cells and aberrant extra-follicular TNF-α accumulation. Parallel peripheral blood studies revealed loss of transitional and follicular B cells in severe disease and accumulation of SARS-CoV-2-specific "disease-related" B cell populations. These data identify defective Bcl-6+ T FH cell generation and dysregulated humoral immune induction early in COVID-19 disease, providing a mechanistic explanation for the limited durability of antibody responses in coronavirus infections, and suggest that achieving herd immunity through natural infection may be difficult.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.cell.2020.08.025

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Self-citation
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Antibody responses to SARS-CoV-2 in patients with COVID-19
Long, Q.-X., Liu, B.-Z., Deng, H.-J., Wu, G.-C., Deng, K., Chen, Y.-K., Liao, P., Qiu, J.-F., Lin, Y., Cai, X.-F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0897-1 · Cited by 2,876
Self-citation
Into the Eye of the Cytokine Storm
Tisoncik, J. R., Korth, M. J., Simmons, C. P., Farrar, J., Martin, T. R., & Katze, M. G. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05015-11 · Cited by 1,940
Germinal Centers
Victora, G. D., & Nussenzweig, M. C. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075032 · Cited by 1,878
Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals
Robbiani, D. F., Gaebler, C., Muecksch, F., Lorenzi, J. C. C., Wang, Z., Cho, A., Agudelo, M., Barnes, C. O., Gazumyan, A., Finkin, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2456-9 · Cited by 1,853
T follicular helper cell differentiation, function, and roles in disease
Crotty, S. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.004 · Cited by 1,847
A serological assay to detect SARS-CoV-2 seroconversion in humans
Amanat, F., Stadlbauer, D., Strohmeier, S., Nguyen, T. H. O., Chromikova, V., McMahon, M., Jiang, K., Arunkumar, G. A., Jurczyszak, D., Polanco, J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0913-5 · Cited by 1,769
Human neutralizing antibodies elicited by SARS-CoV-2 infection
Ju, B., Zhang, Q., Ge, J., Wang, R., Sun, J., Ge, X., Yu, J., Shan, S., Zhou, B., Song, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2380-z · Cited by 1,667 · cited 1×
“In persons with COVID-19, the magnitude and durability of antibody responses are greater in those with more severe disease (Ju et al., 2020; Amanat et al., 2020) but are often of low magnitude (Robbiani et al.”

Flagged first, then by citations

Show all 51 references

1 of the 51 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

Woodruff, 2020, Critically ill SARS-CoV-2 patients display lupus-like hallmarks of extrafollicular B cell activation, medRxiv

Sorted by citations

Items 201–300 of 734

Significance of Conserved Regions in Coronavirus Spike Protein for Developing a Novel Vaccine against SARS-CoV-2 Infection
Olukitibi, T. A., Ao, Z., Warner, B. M., Unat, R., Kobasa, D., & Yao, X. (2023) · Vaccines · doi:10.3390/vaccines11030545 · Cited by 38
Granzyme K– and amphiregulin-expressing cytotoxic T cells and activated extrafollicular B cells are potential drivers of IgG4-related disease
Koga, R., Maehara, T., Aoyagi, R., Munemura, R., Murakami, Y., Doi, A., Kono, M., Yamamoto, H., Niiro, H., Kiyoshima, T., et al. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.11.916 · Cited by 43
Self-citation
A roadmap for defining “extrafollicular” B cell responses
Eisenbarth, S. C., Batista, F. D., Cyster, J. G., Elsner, R. A., Kelsoe, G. H., Lund, F. E., Pillai, S. S., Sanz, I., Shlomchik, M. J., Toellner, K., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.08.007 · Cited by 46
Self-citation
Cutting Edge: Distinct B Cell Repertoires Characterize Patients with Mild and Severe COVID-19
Hoehn, K. B., Ramanathan, P., Unterman, A., Sumida, T. S., Asashima, H., Hafler, D. A., Kaminski, N., Cruz, C. S. D., Sealfon, S. C., Bukreyev, A. A., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100135 · Cited by 40
CD4+ T-cell subsets in autoimmune hepatitis: A review
Chen, H., Han, Z., Fan, Y., Chen, L., Peng, F., Cheng, X., Wang, Y., Su, J., & Li, D. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000269 · Cited by 41
Antigen‐dependent multistep differentiation of T follicular helper cells and its role in SARS‐CoV‐2 infection and vaccination
Baumjohann, D., & Fazilleau, N. (2021) · European Journal of Immunology · doi:10.1002/eji.202049148 · Cited by 40
Of bats and men: Immunomodulatory treatment options for COVID-19 guided by the immunopathology of SARS-CoV-2 infection
Christie, M. J., Irving, A. T., Forster, S. C., Marsland, B. J., Hansbro, P. M., Hertzog, P. J., Nold‐Petry, C. A., & Nold, M. F. (2021) · Science Immunology · doi:10.1126/sciimmunol.abd0205 · Cited by 41
Maturation trajectories and transcriptional landscape of plasmablasts and autoreactive B cells in COVID-19
Schultheiß, C., Paschold, L., Willscher, E., Simnica, D., Wöstemeier, A., Muscate, F., Wass, M., Eisenmann, S., Dutzmann, J., Keyßer, G., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103325 · Cited by 37
The extrafollicular response is sufficient to drive initiation of autoimmunity and early disease hallmarks of lupus
Voss, L. F., Howarth, A. J., Wittenborn, T. R., Hummelgaard, S., Juul‐Madsen, K., Kastberg, K. S., Pedersen, M. K., Jensen, L., Papanastasiou, A. D., Vorup‐Jensen, T., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1021370 · Cited by 38
Coronavirus disease 2019 (COVID-19) and autoimmunity
Nasonov, E. L. (2021) · Rheumatology Science and Practice · doi:10.47360/1995-4484-2021-5-30 · Cited by 41
Lung Protection vs. Infection Resolution: Interleukin 10 Suspected of Double-Dealing in COVID-19
Lindner, H. A., Velásquez, S. Y., Thiel, M., & Kirschning, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.602130 · Cited by 39
Innate Immunity in Protection and Pathogenesis During Coronavirus Infections and COVID-19
Malireddi, R. K. S., Sharma, B. R., & Kanneganti, T. (2024) · Annual Review of Immunology · doi:10.1146/annurev-immunol-083122-043545 · Cited by 39
Germline immunoglobulin genes: Disease susceptibility genes hidden in plain sight?
Collins, A. M., Yaari, G., Shepherd, A. J., Lees, W., & Watson, C. T. (2020) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2020.10.011 · Cited by 36
T follicular helper cells in the humoral immune response to SARS-CoV-2 infection and vaccination
Koutsakos, M., Lee, W. S., Wheatley, A. K., Kent, S. J., & Juno, J. A. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.5mr0821-464r · Cited by 37
A virus-specific monocyte inflammatory phenotype is induced by SARS-CoV-2 at the immune–epithelial interface
Léon, J., Michelson, D. A., Olejnik, J., Chowdhary, K., Oh, H. S., Hume, A. J., Galván-Peña, S., Zhu, Y., Chen, F., Vijaykumar, B., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2116853118 · Cited by 35
Cytotoxic CD8+ T cells may be drivers of tissue destruction in Sjögren’s syndrome
Kaneko, N., Chen, H., Perugino, C. A., Maehara, T., Munemura, R., Yokomizo, S., Sameshima, J., Diefenbach, T. J., Premo, K. R., Chinju, A., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-19397-w · Cited by 39
Self-citation
Robust long-term immunity to SARS-CoV-2 in patients recovered from severe COVID-19 after interleukin-6 blockade
Masiá, M., Fernández‐González, M., García, J. A., Padilla, S., García‐Abellán, J., Botella, Á., Mascarell, P., Agulló, V., & Gutiérrez, F. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104153 · Cited by 44
Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review
Shafqat, A., Shafqat, S., Alsalameh, S., Kashir, J., AlKattan, K. M., & Yaqinuddin, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.835104 · Cited by 37
Structural and immunological basis of cross-reactivity between dengue and Zika infections: Implications in serosurveillance in endemic regions
Gaspar-Castillo, C., Rodriguez, M. H., Ortiz-Navarrete, V. F., Alpuche-Aranda, C. M., & Martínez-Barnetche, J. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1107496 · Cited by 36
The intersection of COVID-19 and autoimmunity: What is our current understanding?
Winchester, N., Calabrese, C. M., & Calabrese, L. H. (2021) · Pathogens and Immunity · doi:10.20411/pai.v6i1.417 · Cited by 40
SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease
D’Silva, K. M., Serling-Boyd, N. J., Hsu, T. Y. T., Sparks, J. A., & Wallace, Z. S. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-219808 · Cited by 33
Mechanisms of Dysregulated Humoral and Cellular Immunity by SARS-CoV-2
Taefehshokr, N., Taefehshokr, S., & Heit, B. (2020) · Pathogens · doi:10.3390/pathogens9121027 · Cited by 35
Memory B cells and serum immunoglobulins are associated with disease severity and mortality in patients with COVID-19
Çölkesen, F., Kurt, E. K., Vatansev, H., Korkmaz, C., Çölkesen, F., Yücel, F., Yıldız, E., Evcen, R., Aykan, F. S., Kılınç, M., et al. (2022) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2021-140540 · Cited by 34
Prior SARS-CoV-2 infection enhances and reshapes spike protein–specific memory induced by vaccination
Barateau, V., Peyrot, L., Saade, C., Pozzetto, B., Brengel‐Pesce, K., Elsensohn, M., Allatif, O., Guibert, N., Compagnon, C., Mariano, N., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.ade0550 · Cited by 33
Vaccination Is the Only Acceptable Path to Herd Immunity
Rasmussen, A. L. (2020) · Med · doi:10.1016/j.medj.2020.12.004 · Cited by 41
Genetic and phenotypic analysis of the causal relationship between aging and COVID-19
Ying, K., Zhai, R., Pyrkov, T. V., Shindyapina, A. V., Mariotti, M., Fedichev, P. O., Shen, X., & Gladyshev, V. N. (2021) · Communications Medicine · doi:10.1038/s43856-021-00033-z · Cited by 37
Alterations in B Cell and Follicular T-Helper Cell Subsets in Patients with Acute COVID-19 and COVID-19 Convalescents
Kudryavtsev, I. V., Arsentieva, N. A., Batsunov, O. K., Korobova, Z. R., Khamitova, I. V., Isakov, D. V., Kuznetsova, R. N., Rubinstein, A., Stanevich, O. V., Lebedeva, A. A., et al. (2021) · Current Issues in Molecular Biology · doi:10.3390/cimb44010014 · Cited by 35
The Immune Response to SARS-CoV-2 Vaccination: Insights Learned From Adult Patients With Common Variable Immune Deficiency
Quinti, I., Locatelli, F., & Carsetti, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.815404 · Cited by 35
Long-Term Persistence of Anti-SARS-COV-2 IgG Antibodies
Yousefi, Z., Taheri, N., Dargahi, M., Chaman, R., Binesh, E., Emamian, M. H., & Jafari, R. (2022) · Current Microbiology · doi:10.1007/s00284-022-02800-0 · Cited by 31
Porcine Respiratory Coronavirus as a Model for Acute Respiratory Coronavirus Disease
Keep, S., Carr, B. V., Lean, F. Z. X., Fones, A., Newman, J., Dowgier, G., Freimanis, G., Vatzia, E., Polo, N., Everest, H., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.867707 · Cited by 33
SARS-CoV-2-specific CD4+ T cells are associated with long-term persistence of neutralizing antibodies
Wang, Z., Yang, X., Mei, X., Zhou, Y., Tang, Z., Li, G., Zhong, J., Yu, M., Huang, M., Su, X., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00978-0 · Cited by 33
SARS-CoV-2 Related Antibody-Dependent Enhancement Phenomena In Vitro and In Vivo
Nakayama, E. E., & Shioda, T. (2023) · Microorganisms · doi:10.3390/microorganisms11041015 · Cited by 32
Why Do Some People Develop Serious COVID-19 Disease After Infection, While Others Only Exhibit Mild Symptoms?
Ballow, M. C., & Haga, C. L. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2021.01.012 · Cited by 34
Functional ACE2 deficiency leading to angiotensin imbalance in the pathophysiology of COVID-19
Cook, J. R., & Ausiello, J. C. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09663-z · Cited by 32
SARS-CoV-2 spike-specific memory B cells express higher levels of T-bet and FcRL5 after non-severe COVID-19 as compared to severe disease
Reyes, R. A., Clarke, K., Gonzales, S. J., Cantwell, A. M., Garza, R., Catano, G., Tragus, R. E., Patterson, T. F., Bol, S. M., & Bunnik, E. M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0261656 · Cited by 33
Engineered Bacteriophage T7 as a Potent Anticancer Agent in vivo
Hwang, Y. J., & Myung, H. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.491001 · Cited by 31
Broad phenotypic alterations and potential dysfunction of lymphocytes in individuals clinically recovered from COVID-19
Yang, J., Zhong, M., Zhang, E., Hong, K., Yang, Q., Zhou, D., Xia, J., Chen, Y.-Q., Sun, M., Zhao, B., et al. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjab014 · Cited by 32
Transcriptome and IgH Repertoire Analyses Show That CD11chi B Cells Are a Distinct Population With Similarity to B Cells Arising in Autoimmunity and Infection
Maul, R. W., Catalina, M. D., Kumar, V. V., Bachali, P., Grammer, A. C., Wang, S., Yang, W. W., Hasni, S., Ettinger, R., Lipsky, P. E., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.649458 · Cited by 32
Rationally designed immunogens enable immune focusing following SARS-CoV-2 spike imprinting
Hauser, B. M., Sangesland, M., Denis, K. S., Lam, E. C., Case, J. B., Windsor, I. W., Feldman, J. E., Caradonna, T. M., Kannegieter, T., Diamond, M., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110561 · Cited by 38
Self-citation
Pharmacological Effects of Ex Vivo Mesenchymal Stem Cell Immunotherapy in Patients with Acute Kidney Injury and Underlying Systemic Inflammation
Swaminathan, M., Kopyt, N. P., Atta, M. G., Radhakrishnan, J., Umanath, K., Nguyen, S., O'Rourke, B. P., Allen, A., Vaninov, N., Tilles, A. W., et al. (2021) · Stem Cells Translational Medicine · doi:10.1002/sctm.21-0043 · Cited by 31
Immune-Guided Therapy of COVID-19
Ferraccioli, G., Gremese, E., Goletti, D., Petrone, L., Cantini, F., Ugel, S., Canè, S., & Bronte, V. (2022) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-0675 · Cited by 30
Multiple Levels of Immunological Memory and Their Association with Vaccination
Bugya, Z., Prechl, J., Szénási, T., Nemes, É., Bácsi, A., & Koncz, G. (2021) · Vaccines · doi:10.3390/vaccines9020174 · Cited by 30
Innate and adaptive immune response in SARS-CoV-2 infection-Current perspectives
Zhu, Q., Xu, Y., Wang, T., & Xie, F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1053437 · Cited by 32
Innate and adaptive immunity to SARS-CoV-2 and predisposing factors
Shen, J., Fan, J., Zhao, Y., Jiang, D., Niu, Z., Zhang, Z., & Cao, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1159326 · Cited by 38
COVID-19: The Emerging Immunopathological Determinants for Recovery or Death
Ahmad, T., Chaudhuri, R., Joshi, M. C., Almatroudi, A., Rahmani, A. H., & Ali, S. M. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.588409 · Cited by 30
Biomaterial-based immunoengineering to fight COVID-19 and infectious diseases
Zarubova, J., Zhang, X., Hoffman, T., Hasani‐Sadrabadi, M. M., & Li, S. (2021) · Matter · doi:10.1016/j.matt.2021.02.025 · Cited by 28
SARS-CoV-2 Impairs Dendritic Cells and Regulates DC-SIGN Gene Expression in Tissues
Cai, G., Bossé, Y., Du, M., Albrecht, H., Qin, F., Luo, X., Luo, X., Androulakis, M., Zhu, X., Zhou, J., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179228 · Cited by 29
Neutralizing antibody: a savior in the Covid-19 disease
Gupta, S. L., & Jaiswal, R. K. (2022) · Molecular Biology Reports · doi:10.1007/s11033-021-07020-6 · Cited by 28
Comparing the Cytokine Storms of COVID-19 and Pandemic Influenza
Pacheco-Hernández, L. M., Ramírez-Noyola, J. A., Gómez-García, I. A., Ignacio-Cortés, S., Zúñiga, J., & Choreño-Parra, J. A. (2022) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2022.0029 · Cited by 29
Activation and pro-inflammatory cytokine production by unswitched memory B cells during SARS-CoV-2 infection
Castleman, M. J., Santos, A. L., Lesteberg, K. E., Maloney, J. P., Janssen, W. J., Mould, K. J., Beckham, J. D., Pelanda, R., & Torres, R. M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1213344 · Cited by 28
mRNA COVID-19 vaccine elicits potent adaptive immune response without the persistent inflammation seen in SARS-CoV-2 infectionPreprint
Ivanova, E. N., Shwetar, J., Devlin, J. C., Buus, T. B., Gray-Gaillard, S. L., Koide, A., Cornelius, A. R., Samanovic, M. I., Herrera, A. M., Mimitou, E. P., et al. (2021) · medRxiv · doi:10.1101/2021.04.20.21255677 · Cited by 29
Histomorphological patterns of regional lymph nodes in COVID-19 lungs
Haslbauer, J. D., Matter, M. S., Stalder, A. K., & Tzankov, A. (2021) · Der Pathologe · doi:10.1007/s00292-021-00945-6 · Cited by 28
Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2
Ahluwalia, P. K., Vaibhav, K., Ahluwalia, M., Mondal, A. K., Sahajpal, N., Rojiani, A. M., & Kolhe, R. B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.660019 · Cited by 25
Deconvoluting the T Cell Response to SARS-CoV-2: Specificity Versus Chance and Cognate Cross-Reactivity
Lehmann, A. A., Kirchenbaum, G. A., Zhang, T., Reche, P. A., & Lehmann, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.635942 · Cited by 27
Double Negative (DN) B cells: A connecting bridge between rheumatic diseases and COVID-19?
Sachinidis, A., & Garyfallos, A. (2021) · Mediterranean Journal of Rheumatology · doi:10.31138/mjr.32.3.192 · Cited by 29
Comprehensive Flow Cytometry Profiling of the Immune System in COVID-19 Convalescent Individuals
Gil-Manso, S., Blanco, I. M., López-Esteban, R., Carbonell, D., López-Fernández, L. A., West, L. J., Correa‐Rocha, R., & Pion, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.793142 · Cited by 30
Hallmarks of Severe COVID-19 Pathogenesis: A Pas de Deux Between Viral and Host Factors
Rovito, R., Augello, M., Ben-Haim, A., Bono, V., Monforte, A. D., & Marchetti, G. C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.912336 · Cited by 27
Delayed generation of functional virus-specific circulating T follicular helper cells correlates with severe COVID-19
Yu, M., Charles, A., Cagigi, A., Christ, W., Österberg, B., Falck‐Jones, S., Azizmohammadi, L., Åhlberg, E., Falck‐Jones, R., Svensson, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37835-9 · Cited by 29
SARS-CoV-2 and the host-immune response
Maison, D. P., Deng, Y., & Gerschenson, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1195871 · Cited by 29
Immune profiling of COVID-19: preliminary findings and implications for the pandemic
Maecker, H. T. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002550 · Cited by 26
The potential of COVID-19 patients’ sera to cause antibody-dependent enhancement of infection and IL-6 production
Shimizu, J., Sasaki, T., Yamanaka, A., Ichihara, Y., Koketsu, R., Samune, Y., Cruz, P., Sato, K., Tanga, N., Yoshimura, Y., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-03273-0 · Cited by 27
Autoantibodies elicited with SARS-CoV-2 infection are linked to alterations in double negative B cells
Castleman, M. J., Stumpf, M. M., Therrien, N. R., Smith, M. J., Lesteberg, K. E., Palmer, B. E., Maloney, J. P., Janssen, W. J., Mould, K. J., Beckham, J. D., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.988125 · Cited by 25
Major alterations to monocyte and dendritic cell subsets lasting more than 6 months after hospitalization for COVID-19
Hopkins, F. R., Govender, M., Svanberg, C., Nordgren, J., Waller, H., Nilsdotter‐Augustinsson, Å., Henningsson, A. J., Hagbom, M., Sjöwall, J., Nyström, S. N., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1082912 · Cited by 26
A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients
Søndergaard, J. N., Tulyeu, J., Edahiro, R., Shirai, Y., Yamaguchi, Y., Murakami, T., Morita, T., Kato, Y., Hirata, H., Takeda, Y., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2217902120 · Cited by 24
COVID-19 and Disease-Modifying Anti-rheumatic Drugs
D’Silva, K. M., & Wallace, Z. S. (2021) · Current Rheumatology Reports · doi:10.1007/s11926-021-00998-9 · Cited by 25
The Mechanisms and Animal Models of SARS-CoV-2 Infection
Jia, W., Wang, J., Sun, B., Zhou, J., Shi, Y., & Zhou, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.578825 · Cited by 27
The impact of hypoxia on B cells in COVID-19
Kotagiri, P., Mescia, F., Hanson, A., Turner, L., Bergamaschi, L., Peñalver, A., Richoz, N., Moore, S. D., Ortmann, B. M., Dunmore, B. J., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103878 · Cited by 27
Association between SARS-CoV-2 RNAemia and dysregulated immune response in acutely ill hospitalized COVID-19 patients
Rovito, R., Bono, V., Augello, M., Tincati, C., Mainoldi, F., Beaudoin-Bussières, G., Tauzin, A., Bianchi, S., Hadla, M., Yellenki, V., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-23923-1 · Cited by 25
Current understanding of T cell immunity against SARS-CoV-2
Lu, X., & Yamasaki, S. (2022) · Inflammation and Regeneration · doi:10.1186/s41232-022-00242-6 · Cited by 23
Lower magnitude and faster waning of antibody responses to SARS-CoV-2 vaccination in anti-TNF-α-treated IBD patients are linked to lack of activation and expansion of cTfh1 cells and impaired B memory cell formation
Garner‐Spitzer, E., Wagner, A., Gudipati, V., Schötta, A., Orola-Taus, M., Kundi, M., Kunert, R., Mayrhofer, P., Huppa, J. B., Stockinger, H. S. J., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104788 · Cited by 25
Antibody and B Cell Responses to SARS-CoV-2 Infection and Vaccination: The End of the Beginning
Röltgen, K., & Boyd, S. D. (2023) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-031521-042754 · Cited by 25
Novel ELISA Protocol Links Pre-Existing SARS-CoV-2 Reactive Antibodies With Endemic Coronavirus Immunity and Age and Reveals Improved Serologic Identification of Acute COVID-19 via Multi-Parameter Detection
Yuen, R. R., Steiner, D., Pihl, R. M. F., Chavez, E. C., Olson, A., Smith-Mahoney, E. L., Baird, L. A., Korkmaz, F. T., Urick, P., Sagar, M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.614676 · Cited by 22
Lethal COVID-19 associates with RAAS-induced inflammation for multiple organ damage including mediastinal lymph nodes
Guarnieri, J. W., Topper, M. J., Beigel, K., Haltom, J., Chadburn, A., Frere, J. J., An, J., Cope, H., Borczuk, A., Sinha, S., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2401968121 · Cited by 30
SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases
Larionova, R., Byvaltsev, K., Kravtsova, O. A., Takha, E., Petrov, S. V., Kazarian, G. G., Рафкатовна, В. А., Shuralev, E. A., Mukminov, M. N., Renaudineau, Y., et al. (2022) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2022.100154 · Cited by 24
mRNA COVID-19 vaccine elicits potent adaptive immune response without the acute inflammation of SARS-CoV-2 infection
Ivanova, E. N., Shwetar, J., Devlin, J. C., Buus, T. B., Gray-Gaillard, S. L., Koide, A., Cornelius, A. R., Samanovic, M. I., Herrera, A. M., Mimitou, E. P., et al. (2023) · iScience · doi:10.1016/j.isci.2023.108572 · Cited by 28
Temporal profiling of human lymphoid tissues reveals coordinated defense against viral challenge
Coates, M. L., Richoz, N., Tuong, Z. K., Bowyer, G., Lee, C. Y. C., Ferdinand, J. R., Gillman, E., McClure, M., Dratva, L. M., Teichmann, S. A., et al. (2025) · Nature Immunology · doi:10.1038/s41590-024-02064-9 · Cited by 26
One-Stop Serum Assay Identifies COVID-19 Disease Severity and Vaccination Responses
Haddad, N. S., Nguyen, D. C., Kuruvilla, M. E., Morrison-Porter, A., Anam, F. A., Cashman, K. S., Ramonell, R. P., Kyu, S. Y., Saini, A. S., Cabrera-Mora, M., et al. (2021) · ImmunoHorizons · doi:10.4049/immunohorizons.2100011 · Cited by 29
Discovery and characterization of high-affinity, potent SARS-CoV-2 neutralizing antibodies via single B cell screening
Schardt, J. S., Pornnoppadol, G., Desai, A. A., Park, K. S., Zupancic, J. M., Makowski, E. K., Smith, M. D., Chen, H., Barbosa, M. G. D. M., Cascalho, M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-99401-x · Cited by 23
Immune interventions in COVID-19: a matter of time?
Plaçais, L., Richier, Q., Noël, N., Lacombe, K., Mariette, X., & Hermine, O. (2021) · Mucosal Immunology · doi:10.1038/s41385-021-00464-w · Cited by 22
Lymphatic coagulation and neutrophil extracellular traps in lung-draining lymph nodes of COVID-19 decedents
MacDonald, M., Weathered, R. K., Stewart, E. C., Magold, A. I., Mukherjee, A., Gurbuxani, S. K., Smith, H., McMullen, P., Mueller, J. S., Husain, A. N., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022007798 · Cited by 24
The immune response as a double‐edged sword: The lesson learnt during the COVID ‐19 pandemic
Agrati, C., Carsetti, R., Bordoni, V., Sacchi, A., Quintarelli, C., Locatelli, F., Ippolito, G., & Capobianchi, M. R. (2022) · Immunology · doi:10.1111/imm.13564 · Cited by 22
Atypical and non-classical CD45RBlo memory B cells are the majority of circulating SARS-CoV-2 specific B cells following mRNA vaccination or COVID-19
Priest, D. G., Ebihara, T., Tulyeu, J., Søndergaard, J. N., Sakakibara, S., Sugihara, F., Nakao, S., Togami, Y., Yoshimura, J., Ito, H., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50997-4 · Cited by 24
Human antiviral B cell responses: Emerging lessons from hepatitis B and COVID‐19
Burton, A. R., & Maini, M. K. (2021) · Immunological Reviews · doi:10.1111/imr.12953 · Cited by 24
T-Cell Immune Responses to SARS-CoV-2 Infection and Vaccination
Notarbartolo, S. (2024) · Vaccines · doi:10.3390/vaccines12101126 · Cited by 23
Polymeric Pathogen-Like Particles-Based Combination Adjuvants Elicit Potent Mucosal T Cell Immunity to Influenza A Virus
Kingstad-Bakke, B. A., Toy, R., Lee, W., Pradhan, P., Vogel, G., Marinaik, C. B., Larsen, A., Gates, D. E., Luu, T., Pandey, B., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.559382 · Cited by 22
Hemolysis-associated phosphatidylserine exposure promotes polyclonal plasmablast differentiation
Vijay, R., Guthmiller, J. J., Sturtz, A. J., Crooks, S. D., Johnson, J. T., Li, L., Lan, L. Y.-L., Pope, R. L., Chen, Y., Rogers, K. J., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20202359 · Cited by 23
Mining of linear B cell epitopes of SARS-CoV-2 ORF8 protein from COVID-19 patients
Wang, X., Lam, J.-Y., Chen, L., Au, S. W., To, K. K., Yuen, K., & Kok, K. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1931465 · Cited by 22
SARS-CoV-2 vaccination washes away original antigenic sin
Pillai, S. S. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.02.009 · Cited by 21
Self-citation
Marginal Zone B-Cell Populations and Their Regulatory Potential in the Context of HIV and Other Chronic Inflammatory Conditions
Doyon-Laliberté, K., Aranguren, M., Poudrier, J., & Roger, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063372 · Cited by 23
Immune features of COVID-19 convalescent individuals revealed by a single-cell RNA sequencing
Zhao, P., Zou, J., Zhou, F., Zhu, Y., Song, Q., Yu, D., & Li, X. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108767 · Cited by 21
Immune responses to SARS-CoV-2 in dialysis and kidney transplantation
Cantarelli, C., Angeletti, A., Perin, L., Russo, L. S., Sabiu, G., Podestà, M. A., & Cravedi, P. (2022) · Clinical Kidney Journal · doi:10.1093/ckj/sfac174 · Cited by 22
Longitudinal whole blood transcriptomic analysis characterizes neutrophil activation and interferon signaling in moderate and severe COVID-19
Prebensen, C., Lefol, Y., Myhre, P. L., Lüders, T., Jonassen, C. M., Blomfeldt, A., Omland, T., Nilsen, H. L., & Berdal, J. (2023) · Scientific Reports · doi:10.1038/s41598-023-37606-y · Cited by 23
Expansion of CD4+ cytotoxic T lymphocytes with specific gene expression patterns may contribute to suppression of tumor immunity in oral squamous cell carcinoma: single-cell analysis and in vitro experiments
Hu, C., Sameshima, J., Yokomizo, S., Sueyoshi, T., Nagano, H., Miyahara, Y., Sakamoto, T., Fujii, S., Kiyoshima, T., Guy, T. V., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1305783 · Cited by 23
Self-citation
Systemic and mucosal immune profiling in asymptomatic and symptomatic SARS-CoV-2–infected individuals reveal unlinked immune signatures
Ravichandran, S., Grubbs, G., Tang, J., Lee, Y., Huang, C., Golding, H., & Khurana, S. (2021) · Science Advances · doi:10.1126/sciadv.abi6533 · Cited by 22
Long-term decay of anti-RBD IgG titers after BNT162b2 vaccination is not mirrored by loss of neutralizing bioactivity against SARS-CoV-2
Malipiero, G., D’Agaro, P., Segat, L., Moratto, A., & Villalta, D. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.11.023 · Cited by 22
Association of follicular helper T and follicular regulatory T cells with severity and hyperglycemia in hospitalized COVID-19 patients
Zahran, A. M., Abdel-Rahim, M. H., Nasif, K. A., Hussein, S., Hafez, R. M. M., Ahmad, A. B., Saad, K., Elhoufey, A. A., Hussein, H. A. M., Thabet, A. A., et al. (2022) · Virulence · doi:10.1080/21505594.2022.2047506 · Cited by 21
Plasma metabolome and cytokine profile reveal glycylproline modulating antibody fading in convalescent COVID-19 patients
Yang, Z., Wu, D., Lu, S., Qiu, Y., Hua, Z., Tan, F., Zhang, C., Zhang, L., Zhang, D., Zhou, X., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2117089119 · Cited by 20
Transient anti-cytokine autoantibodies superimpose the hyperinflammatory response in Kawasaki disease and multisystem inflammatory syndrome in children: a comparative cohort study on correlates of disease
Netea, S. A., Biesbroek, G., van Stijn, D., IJspeert, H., van der Made, C. I., Jansen, M. H., Geissler, J., van den Berg, J. M., van der Kuip, M., Gruppen, M. P., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104736 · Cited by 21
B cell depletion and signs of sepsis-acquired immunodeficiency in bone marrow and spleen of COVID-19 deceased
Ihlow, J., Michaelis, E. G., Greuel, S., Heynol, V., Lehmann, A., Radbruch, H., Meinhardt, J., Miller, F., Herbst, H., Corman, V. M., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.12.078 · Cited by 21
Coronavirus-specific antibody production in middle-aged mice requires phospholipase A2G2D
Zheng, J. H., Meyerholz, D. K., Wong, L.-Y. R., Gelb, M. H., Murakami, M., & Perlman, S. M. (2021) · Journal of Clinical Investigation · doi:10.1172/jci147201 · Cited by 21

Authors: Kaneko, N., Kuo, H.-H., Boucau, J., Farmer, J. R., Allard-Chamard, H., Mahajan, V. S., Piechocka-Trocha, A., Lefteri, K., Osborn, M., Bals, J., Bartsch, Y. C., Bonheur, N., Caradonna, T. M., Chevalier, J., Chowdhury, F., Diefenbach, T. J., Einkauf, K., Fallon, J., Feldman, J., Finn, K. K., Garcia-Broncano, P., Hartana, C. A., Hauser, B. M., Jiang, C., Kaplonek, P., Karpell, M., Koscher, E. C., Lian, X., Liu, H., Liu, J., Ly, N. L., Michell, A. R., Rassadkina, Y., Seiger, K., Sessa, L., Shin, S., Singh, N., Sun, W., Sun, X., Ticheli, H. J., Waring, M. T., Zhu, A. L., Alter, G., Li, J. Z., Lingwood, D., Schmidt, A. G., Lichterfeld, M., Walker, B. D., Yu, X. G., Padera, R. F., & Pillai, S.
Affiliations: Ragon Institute of MGH, MIT and Harvard (US)
Brigham and Women's Hospital (US)
Howard Hughes Medical Institute (US)
Harvard University (US)
Corresponding author: Padera, Robert F.
Pillai, Shiv
ORCID: Kaneko, Naoki
Kuo, Hsiao-Hsuan
Boucau, Julie
Farmer, Jocelyn R.
Allard-Chamard, Hugues
Mahajan, Vinay S.
Osborn, Matthew
Bals, Julia
Bartsch, Yannic C.
Caradonna, Timothy M.
Chevalier, Josh
Chowdhury, Fatema
Diefenbach, Thomas J.
Einkauf, Kevin
Fallon, Jon
Feldman, Jared
Garcia-Broncano, Pilar
Hartana, Ciputra Adijaya
Hauser, Blake M.
Jiang, Chenyang
Lian, Xiaodong
Liu, Hang
Michell, Ashlin R.
Rassadkina, Yelizaveta
Seiger, Kyra
Sessa, Libera
Shin, Sally
Singh, Nishant
Sun, Weiwei
Sun, Xiaoming
Waring, Michael T.
Zhu, Alex L.
Alter, Galit
Li, Jonathan Z.
Lingwood, Daniel
Schmidt, Aaron G.
Lichterfeld, Mathias
Walker, Bruce D.
Yu, Xu G.
Padera, Robert F.
Pillai, Shiv
Venue: Cell
Publisher: Elsevier BV
Published: 2020-10
Volume: 183
Issue: 1
Pages: 143-157.e13
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/j.cell.2020.08.025
PMC: PMC7437499
OpenAlex: W3049048202
Cited by: 734
References: 51
Citations by year: 2026: 31 · 2025: 48 · 2024: 69 · 2023: 105 · 2022: 174 · 2021: 244 · 2020: 62
FWCI: 19.19
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 365 d)
Locations: Cell (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Keywords: COVID-19 pandemic, SARS-CoV-2, BCL6, T follicular helper cells, germinal center, humoral immune response, T-bet, Th1 cells, TNF-α, transitional B cells, follicular B cells, spleen, herd immunity
MeSH terms: COVID-19, Aged, Aged, 80 and over, B-Lymphocytes, Female, T-Lymphocytes, Helper-Inducer, Humans, Male, Middle Aged, Pneumonia, Viral, Spleen, Tumor Necrosis Factor-alpha, Coronavirus Infections, Germinal Center, Proto-Oncogene Proteins c-bcl-6, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks